Oklahoma SB1563 modifies Medicaid drug formulary restrictions and prohibits certain carriers from imposing specified utilization controls on.
Oklahoma SB1563 amends the state Medicaid program to modify restrictions on the Medicaid drug formulary, ensuring nonopioid drugs for pain management are not disadvantaged compared to opioid drugs. The bill defines "nonopioid drug" and prohibits the Authority or a contracted entity from denying coverage of a nonopioid drug in favor of an opioid drug. It also authorizes carriers of state employee flexible benefit plans to adopt a state preferred drug list (PDL) but prohibits them from imposing more restrictive or extensive utilization controls for nonopioid drugs than those applied to opioid.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.